In IBC, STAT3 has been implicated to play a crucial role, because IL-6, an inflammatory cytokine that activates the STAT signaling pathway, is up-regulated in IBC tumors compared to nIBC [58]. This evidence concerns the gene IL6 and inflammatory breast carcinoma.